Ovid Therapeutics Inc. (OVID) Net margin 2020–2025
Ovid Therapeutics Inc. (OVID) net profit margin by fiscal year — reported net income divided by reported revenue.
-240.1%FY2025 · since FY2020: -642.3% → -240.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -240.1% | +4430.0 pp |
| FY2024 | -4670.1% | +8681.6 pp |
| FY2023 | -13351.8% | -9747.1 pp |
| FY2022 | -3604.7% | -3663.6 pp |
| FY2021 | 58.9% | +701.2 pp |
| FY2020 | -642.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More OVID financial trends
OVID RevenueOVID Net incomeOVID Gross profitOVID Gross marginOVID Operating incomeOVID Operating marginOVID Operating cash flowOVID Free cash flowOVID Capital expendituresOVID Return on equityOVID Stock buybacksOVID Dividends paidOVID Total assetsOVID Total liabilitiesOVID Shareholders’ equityOVID overview →